Telomerase levels change in OFFER study
Published: 2 August 2017| Version 1 | DOI: 10.17632/csz5rw8fyk.1
Contributors:
Tomasz Pawelczyk, Marta Grncow-Grabka, Elżbieta Trafalska, Janusz Szemraj, Natalia Żurner, Agnieszka PawełczykDescription
Changes in telomerase levels during 26-weeks supplementation of n-3 PUFA or placebo (olive oil) in first-episode schizophrenia patients.
Files
Categories
Psychiatry, Schizophrenia, Telomerase